Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation.
about
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionTranscriptional repression of mitochondrial function in aging: a novel role for the silencing mediator of retinoid and thyroid hormone receptors co-repressorEnergy metabolism in the liverPPARγ as a therapeutic target to rescue mitochondrial function in neurological diseasePPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Retinoic acid-related orphan receptor γ (RORγ): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivityPPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivityLipid metabolites as metabolic messengers in inter-organ communication.Molecular pathways in non-alcoholic fatty liver disease.Increased fat mass is associated with increased bone size but reduced volumetric density in pre pubertal childrenA diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use.Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol diet.Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet.MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathwaysMisregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity.Direct control of hepatic glucose production by interleukin-13 in mice.Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptorsCombined pharmacological activation of AMPK and PPARδ potentiates the effects of exercise in trained mice.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.Genetic dissection of retinoid esterification and accumulation in the liver and adipose tissue.PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue.Overfeeding Dairy Cattle During Late-Pregnancy Alters Hepatic PPARα-Regulated Pathways Including Hepatokines: Impact on Metabolism and Peripheral Insulin Sensitivity.Pharmacological agents for NASH.Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity.Evolving therapies for non-alcoholic steatohepatitis.PPARs and ERRs: molecular mediators of mitochondrial metabolism.Phytoceramide and sphingoid bases derived from brewer's yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.Distinct but complementary contributions of PPAR isotypes to energy homeostasis.
P2860
Q24601222-D08ECFE0-7378-487C-A59A-0329008918A4Q26992046-3378E4EE-E6A0-462E-A3C5-E5AAFF133750Q26996783-E3780017-9007-45C6-9D51-48AA478CC980Q28069549-964F22E0-4F1E-41C6-8121-F94F4AF004C6Q30241952-0B7B2523-5BCD-4AC5-B659-CDD0729EF0D1Q33617767-B77D1EE5-2248-401B-9192-F8FFC67AB71BQ33825128-119273BB-DA0D-41C0-9596-D7E866D83D16Q33831533-0F4CF818-CCD4-4332-B22B-CB83285D1D6CQ33890230-A5AA59F0-590C-4A7C-A66E-1F00F160E211Q33907379-9D812757-BDE0-4CC1-8559-9D7B2F9AD37AQ34078111-A81E790A-5B36-40C6-B003-F7DF4798F320Q35084113-422E8F6C-F540-48E2-BB9F-919F80D2E46EQ35569436-7FF24C87-D16D-45C1-A9DA-680D9E39320EQ35592839-E0350730-349C-4B45-B40B-37651CF846D2Q35613331-D82C1074-96D1-494B-9D28-DB8E55B18804Q35716907-9C19EC0B-D428-43AA-9DDE-C97B017329B0Q35920226-33A0B801-E7C9-4531-BAED-1D419447A134Q36176775-01D74249-78C0-4D75-849A-A61C323F0F1CQ36253614-92CBE434-0ADA-4236-AF4D-63D318137EE4Q36385717-F64DB989-FB2E-46DC-8ED8-F820A1DFAA64Q36478196-AFA18CA3-5569-4354-8E83-DCFF50E792C5Q36497258-9E5D5778-D954-42FB-B7CA-5F3CE96D4C7AQ36733873-8D0BE635-0409-4ACE-AC33-12701544D018Q36773746-2250CFD3-1482-40A5-988B-82187AC5C101Q37575571-1F545224-582F-4CF0-965C-E3B179FA6CCFQ37590272-FEA0AD46-D551-488E-B7A8-D8D212DAAE5BQ37625952-9B04DCB3-2FBF-4CA1-9F33-5DB14E17EA2CQ37649336-E241A3DB-8D00-4E46-A162-9BBBC75082EAQ37694629-032BCDD2-E3B9-4724-AC8B-4142D238E3A8Q38152646-A071E021-02D7-49E8-8980-FDCB0FD3DC4CQ38197690-2512570C-3DBB-4031-A8A6-FCABC1801812Q38207111-ABFED11B-B6D6-44D3-845E-AAFDE2772174Q38285171-3E8FFFA4-71BC-4890-AF75-A3AB895CB7F3Q38520014-624044C9-F6D7-4C71-98DB-E736A04AD4D4Q38674739-FF9C0017-B298-4851-B4F7-B6548C534E2AQ38698442-5106A7AA-BB19-4CCB-9F07-21242BF75F8EQ38752520-E0E3EDB6-1C30-4612-98CF-2F77A4B66C64Q39044686-A81E0128-8FDD-4CD6-BCE0-AFFB4966EC77Q39090639-BE4438BE-CDD3-4ACD-BC2B-A92E171FC27BQ39214885-BC7E4FFF-8F46-4F59-9A84-29EC737AB6B2
P2860
Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@ast
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@en
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@nl
type
label
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@ast
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@en
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@nl
prefLabel
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@ast
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@en
Role of peroxisome proliferato ...... hepatic metabolic regulation.
@nl
P2093
P2860
P356
P1476
Role of peroxisome proliferato ...... n hepatic metabolic regulation
@en
P2093
Ben Hatano
Cem Gorgun
Chen-Chung Yen
Chih-Hao Lee
James A Balschi
James M Ntambi
Kihwa Kang
Matthew R Gangl
Minghui Zhao
P2860
P304
P356
10.1074/JBC.M110.138115
P407
P577
2010-11-08T00:00:00Z